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Summary 
Helper T cell recognition of antigen requires that it be processed within antigen-presenting cells 
(APC) to peptide fragments that subsequently bind to major histocompatibility  complex (MHC) 
class II molecules and are displayed on the APC surface. Heretofore, processed antigen-MHC 
class II complexes have been detected by functional assays, measuring the activation of specific 
T cells. We now report direct, biochemical evidence for the assembly of processed antigen-MHC 
class II complexes within  splenic  B  ceils as APC.  The I-E  k MHC  class II molecules were 
immunoprecipitated from B cells that had processed  the model protein antigen cytochrome c 
radiolabeled  across its entire length by reductive methylation of lysine residues and covalently 
coupled to Ig-specific antibodies, allowing internalization  after binding to surface Ig. Our previous 
studies showed that I-E  ~ immunoaffinity purified from B cells that had processed cytochrome 
c contains functional processed antigen-MHC class II complexes and that approximately 0.2% 
of the I-E  k molecules are specifically associated with one of two predominant processed antigenic 
fragments. Here we show that these complexes are rapidly assembled, within 30--60 min after 
antigen binding to surface Ig on splenic B cells. Maximal numbers of complexes are assembled 
by 2 h in a process that is sensitive to acidic vesicle inhibitors but not to inhibitors of protein 
synthesis.  The processed  antigen-I-E  k complexes have a relatively short half-life of 2--4 h and 
are disassembled or degraded within 8 h after antigen is first internalized. The disassembly or 
degradation of the processed antigen-I-E  k complexes requires acidic vesicle function, and in the 
presence of an acidic vesicle inhibitor the complexes are long lived. Thus, using a biochemical 
assay to monitor processed antigen-I-E  k complexes, we find that, in B cells, processed antigen 
is relatively rapidly associated in acidic vesicles with preexisting MHC class II molecules, and 
the complexes are disassembled 4-6 h later in processes that also require acid vesicle function. 
I 
't is well established that the recognition of protein antigens 
by helper T lymphocytes requires the processing and pre- 
sentation of the antigen by APC (1). Most of our under- 
standing of the events in the processing pathway comes from 
studies of the effects of cellular inhibitors on the ability of 
an APC provided with a native antigen to stimulate specific 
T cells, and from analyses of the ability of APC to stimulate 
T  cells when provided with synthetic peptides that mimic 
processed antigen. Results of such studies have lent valuable 
insights to the antigen processing pathway, indicating that 
antigen is taken into an acidic compartment within APC where 
proteolysis proceeds, producing peptide fragments that ulti- 
mately bind to the MHC class II molecules and are subse- 
quently displayed  on the APC surface for recognition by 
specific T cells. Here we describe a biochemical assay for the 
assembly of processed antigen-MHC class II complexes and 
show that in B cells, as APC, the formation of such com- 
plexes does not require new protein synthesis and both the 
assembly and disassembly of complexes requires acidic vesicle 
function. 
APC internalize antigen either by fluid phase pinocytosis 
or, in a more efficient fashion, by receptor-mediated endocy- 
tosis, which for B cells is accomplished by antigen binding 
to specific surface Ig (2). The discrete compartments in which 
antigen is degraded and in which peptides bind to MHC class 
II have not yet been identifed. As for most membrane pro- 
teins, the ce and/3 chains of the MHC dass II molecules are 
synthesized in the endoplasmic reticulum (ER). 1 Within 
minutes of synthesis, they associate with invariant chains (Ii) 
and are transported through the Golgi apparatus with a half- 
1  Abbreviations used in this paper: DMc, 3H-Drosophila melanogaster cyto- 
chrome c; EIL, endoplasmic  reticulum; Ii, invariant chains; Pc, pigeon 
cytochrome  c. 
425  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/92/02/0425/12  $2.00 
Volume 175  February  1992  425-436 time of 30-60 min (3-5). The MHC class II resides in a post- 
Golgi compartment, during which time the Ii chain dissociates 
(4,  6).  This compartment is able to fuse with pinocytotic 
vesicles carrying antigen into the cell (4, 7). Recent studies 
indicate that MHC class II bound to Ii cannot bind peptide 
(8, 9),  suggesting that Ii functions to insure that peptides 
do not bind to the MHC class II until it reaches a post-Golgi 
compartment that intersects with exogenous antigen. Brodsky 
and coworkers (10) have shown by immunoelectron micros- 
copy that within minutes of binding to surface Ig, antigen 
is internalized into compartments that contain MHC class 
II, Ii, and the proteases cathepsin B and D. As this compart- 
ment contains all the cellular machinery presumed necessary 
for antigen processing, it has been suggested as a processing 
site, although functional data remain to be provided. Harding 
et al. (11) have recently shown that in macrophages, for the 
antigen lysozyme, processing requires a lysosomal/late en- 
dosomal function, and have proposed that processed peptides 
are transported from the lysosomes to vesicles containing MHC 
dass II. Protein synthesis inhibitors have been shown to block 
antigen presentation (12-14),  as has treatment with brefeldin 
A (13, 14), which blocks transport of proteins from the ER, 
suggesting that newly synthesized MHC class II molecules 
are required for assembly of peptide-MHC class II complexes. 
However, the possibility that cell surface MHC class II recycles 
into the cell and binds peptide has not been ruled out.  In- 
deed, recent evidence indicates that MHC class II in B cells 
rapidly recycles, providing the opportunity for binding to 
processed antigen (15-17). 
The assembly of processed antigen-MHC class II com- 
plexes has not been studied directly in the APC, most likely 
due to the fact that only a small number of processed an- 
tigen-MHC class II complexes are assembled in APC.  In- 
deed, recent estimates indicate that this number is between 
50 and 1,000/APC (18-20). Synthetic antigenic peptides have 
been shown to bind to purified MHC class II molecules in 
detergent solution (21, 22) and in planar membranes (23) in 
vitro. The binding kinetics in vitro are unusual in that the 
association rate is extremely slow and, once bound, the off 
rate is negligible, making peptide binding to MHC class II 
nearly irreversible  (22).  Indeed,  Lee and Watts  (24)  have 
shown that the release of peptide from MHC class II in vitro 
requires extreme conditions (pH 2 for 2 h). At present, it 
is not known if the measurements of peptide binding to ma- 
ture MHC class II molecules in vitro are a true reflection 
of the assembly of newly processed antigen and MHC class 
II complexes inside the cell. Indeed, recent studies by Jensen 
(25)  and Wettstein et al.  (26)  showed that the binding of 
peptide to MHC class II in vitro is facilitated by acidic pH, 
suggesting that the microenvironment in which peptide en- 
counters MHC class II may dramatically affect assembly. 
Here we report the kinetics of the assembly and disassembly 
of processed antigen-MHC class II complexes in splenic B 
cells. The work to be described is based on our previous results, 
which showed that  the I-E  k MHC  class II molecules im- 
munoaffinity purified from APC that have processed the an- 
tigen cytochrome c are stimulatory to specific T cells when 
incorporated into liposomes in the absence of any additional 
antigen (27). This unequivocally demonstrated that functional, 
naturally processed,  antigenic peptide-I-E  k complexes are 
stable during immunoaffiuity  purification.  Subsequent studies, 
in which I-E  k was immunoaffinity purified from cells that 
had processed radiolabeled cytochrome c, allowed the quan- 
titation and characterization of the naturally processed ra- 
diolabeled peptides bound to the I-E  k molecules (20). These 
results showed that '~0.2%  of I-E  k contains processed an- 
tigen composed of two predominant peptides and that the 
association is highly specific in that the processed antigen 
bound to I-E  k was not identical to that bound to I-A  k and 
no processed antigen bound to class I Kk/D  k. We describe 
now the assembly of processed antigen-I-E  k complexes in 
splenic B cells after antigen binding to surface Ig. The an- 
tigen monitored is radiolabeled cytochrome c covalently cou- 
pled to antibodies specific for mouse Ig, allowing efficient 
internalization into B cells (28). Processed antigen-MHC class 
II complexes were detected by immunoprecipitating the MHC 
class II and monitoring radioactivity. We found that antigen 
bound to surface Ig is rapidly internalized and degraded into 
small molecular weight products within an hour. Processed 
antigen-MHC class II complexes form 1 h after antigen is 
internalized and are transiently observed over a 4-h period. 
Processed antigen-MHC class II complexes are not assem- 
bled in the presence of NH4C1,  a documented inhibitor of 
antigen presentation to T  cells (1). However, the assembly 
of the peptide-MHC dass II complexes is not blocked by 
inhibitors of protein synthesis which also have been shown 
to inhibit antigen presentation (12-14),  distinguishing the 
assembly of the complexes from their presentation to T cells. 
By 6-8 h, the processed antigen-MHC class II complexes are 
no longer detectable even though there is no appreciable turn- 
over of the MHC class II molecules during this time. In the 
presence of NH4C1,  the processed antigen-MHC  class  II 
complexes are found to be long lived, demonstrating that 
the disassembly or degradation of these complexes requires 
acidic vesicle function. Thus, in contrast to the kinetics of 
peptide-MHC class II complex formation in vitro, the ki- 
netics in vivo reported here show that splenic B cells rapidly 
associate  processed antigen with MHC  class II in an acid 
vesicle-dependent manner, and disassemble or degrade these 
complexes in an acid vesicle-dependent pathway 4-6 h later. 
Materials and Methods 
Preparation of B Cells.  B cells were obtained from mouse spleens 
as described (29). Briefly, spleens were isolated from CBA/J mice 
(The Jackson Laboratory, Bar Harbor, ME) and perfused  with DME 
to release  cells into a single cell suspension. The spleens were teased 
to remove any residual cells. The single cell suspension was washed 
once with DME and resuspended at 2 ml/spleen. The single cell 
suspension was transferred to vacutainer tubes (Becton Dickinson 
& Co., Mountain View, CA) at 4 ml per tube, underlaid with 4 
ml of Histopauge 1119 (Sigma Chemical Co., St. Louis, MO) and 
spun at 1,200 g for 15 min to remove red blood cells. The cells 
at the interface were harvested, washed twice with DME, and 
counted. The cells were depleted of T cells by complement lysis 
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1.2 (AT83A) and rabbit complement. The cells were then washed 
to remove cell debris and resuspended in complete medium to the 
desired  concentration. 
Reductive Methylation of Pigeon Cytochrome c (Pc).  Pc was meth- 
ylated according to Jentoft and Dearborn (30). Pc was dissolved at 
2 mg/ml in 10 mM P04, pH 7.0, and either sodium cyanoboro- 
hydride (Aldrich Chemical Co., Milwaukee,  WI) or 3H-sodium 
cyanoborohydride (Amersham Corp., Arlington Heights, IL). Form- 
aldehyde (1 M in 10 mM PO4, pH 7.0) was added such that the 
molar ratio of the reactants was 1:64:64 respectively. The reaction 
was allowed to proceed for 4 h at room temperature. The methyl- 
ated Pc was separated  from excess reactants by gel filtration on a 
Sephadex G-25 column. Methylated Pc products were separated using 
a mono S HR 5/5 column (Pharmacia Fine Chemicals,  Piscataway, 
NJ) equilibrated in 10 mM P04, pH 7.0, buffer. The sample was 
eluted using a linear gradient over 60 min with 10 mM P04, 250 
mM NaC1. Fractions (1 ml) were collected. For ~H-PC, an aliquot 
of each fraction was removed for liquid scintillation counting. For 
nonradioactive methylated Pc, fractions were buffer changed into 
PBS for use in tissue  culture experiments. 
Preparation of Methflated-Pc-Anti-Ig.  Pc  was  thiolated  using 
2-iminothiolane (Pierce Chemical Co., Rockford, IL) at a molar 
ratio of 1:0.06, for 30 min at 4~  The low 2-iminothiolane-to-Pc 
ratio was selected to produce monothiolated Pc so as to maintain 
the antigenicity of the thiolated Pc and to prevent polymerization. 
The thiolated Pc was separated from unmodified Pc by affinity chro- 
matography on activated-thiol-propyl  Sepharose 4B (Pharmacia Fine 
Chemicals) by incubating Pc overnight with the thiol gel, washing 
the gel free of unbound Pc, and then eluting thiolated Pc with 50 
mM DTT, pH 8. Approximately 3% of the total Pc is bound to 
the thiol-propyl sepharose indicating that a low level of thiolation 
was achieved. The eluted thiol-Pc was buffer changed into 10 mM 
PO4, 1 mM EDTA, 1.5 mM DTT, pH 7.0, using a Sephadex G-25 
column, and concentrated to 2 mg/ml in a Centricon 10 (Amicon 
Corp., Danvers,  MA). The thiolated-Pc  was reductively methyl- 
ated using either sodium cyanoborohydride (Aldrich Chemical Co.) 
or 3H-sodium  cyanoborohydride and  concentrated as  described 
above. Rabbit anti-mouse F(ab')2 (Pierce Chemical Co.) was re- 
acted with a 10-fold molar excess of N-succinimidyl 3-(2-pyridyl- 
dithio) propionate (SPDP) (Pierce Chemical Co.) for 30 rain at room 
temperature. The modified antibody was buffer changed into 10 mM 
PO4,  150 mM NaC1 pH 8.0 using a Sephadex G-25 column, and 
then concentrated to '~1 ml using a Centricon 30. The methylated- 
thiolated-pc was  reacted with SPDP-modified antibody for 16 h 
at room temperature. The resulting methylated-Pc-anti-Ig  was sepa- 
rated from methylated-Pc by gel filtration chromatography on a 
Sephadex G-75 column. The ratio of 3H-Pc to anti-Ig in the con- 
jugates ranged in different preparations from 1:3 to 1:5. The specific 
activity of the 3H-PC was 4-6  x  1016 cpm/mol Pc. 
Assay.for Antigen Internalization and Degradation,  B calls were 
incubated with 0.2/zM 3H-Pc-anti-Ig  on ice for 1 h in the pres- 
ence of 25% normal rabbit serum, pelleted, and washed twice with 
FCS. The washed cells were resuspended  at 2  x  107 cells/ml, and 
I ml of the call suspension  was aliquoted for each time point. The 
cells were rapidly warmed to 37~  incubated for the desired time, 
and then pelleted. The supernatant was removed and designated 
the released fraction. The cells were resuspended in 0.2 mM HC1, 
150 mM NaC1 and incubated for 15 min on ice. The cells were 
again pelleted, and the supernatant was removed and designated 
the surface fraction. The cell pellet was resuspended and designated 
the internal fraction. A portion of each fraction was counted by 
liquid scintillation.  The remainder of each fraction was precipitated 
with TCA (10% final concentration) for 90 min. The precipitate 
was pelleted and a portion of the supernatant removed for counting. 
Immunotnecipitation ofPeptide-I-E  k Complexes.  B cells (10  s) were 
incubated as above with 3H-Pc-anti-Ig for 1 h on ice, washed and 
incubated at 37~  for varying lengths of time, washed, and pelleted. 
The cell pellet was lysed in 0.15 M NaC1 containing 0.05 M Tris, 
5 mM EDTA, 0.5% NP-40, 200/zg/ml PMSF (Boehringer Mann- 
heim Biochemicals,  Indianapolis,  IN),  and 25 #g/ml Aprotinin 
(Boehringer Mannheim Biochemicals),  pH 7.6, for 45 min on ice 
with frequent vortexing (31). The lysate was cleared of debris by 
centrifuging, first at 1,200 g for 30 min, then at 100,000 g for 1 h. 
The lysate was incubated twice at 4~  for 1.5 h with 800/zl of 
a 1:1 protein A-Sepharose slurry (Pharmacia Fine Chemicals).  The 
lysate was incubated for 15 h at 4~  with 30/zg of mAbs specific 
for either I-E  ~, 14.4.4S (32), or for B220, 14.8 (33), that had been 
preabsorbed to 120 #1 of a 1:1 protein A-Sepharose slurry. After 
incubation, protein A-Sepharose was washed with 0.15 M NaC1, 
0.05 M  Tris, 5 mM EDTA, 0.2%  NP-40 until the washes  con- 
tained no tritium as assayed by liquid scintillation counting. The 
protein A-Sepharose was resuspended in 62.5 mM Tris, pH 6.8, 
2% SDS buffer for 15 min to release the bound material. The pro- 
tein A-Sepharose was pelleted and the radioactivity in the superna- 
rant and on the Sepharose beads determined. No radioactivity was 
detected associated with the beads indicating all bound material 
had been eluted. 
When indicated B cells were surface iodinated (34) before im- 
munoprecipitation of I-E  k. B cells (1.5  x  10  s) were washed three 
times  with  10  mM  PO4,  150  mM  NaC1,  pH  7.4  (PBS), 
resuspended at 3  x  10  s cell/ml in PBS, and chilled on ice. 20 #1 
of 10 #M Na2SO3 and 40 #1 100 mM PO~, pH 7.0,  was added 
to 1 mCi NaI (ICN Biomedicals,  Irvine, CA) for a total volume 
of 78 #1. Lactoperoxidase (Calbiochem-Behring Corp., San Diego, 
CA) (20 U) and the NaI solution were sequentially added to the 
cells and mixed. Hydrogen peroxide (1.8 mM) was added in six 
50-#1 aliquots at 2-min intervals.  Cells were washed twice with 
PBS, then four times with DME. The cells were 93% viable by 
trypan blue exclusion. Immunoprecipitation  was carried out as above. 
Treatment of  B Cells with Inhibitors.  B cells were incubated with 
NH4C1 (10 mM) for 1 h before the addition of 3H-pc-anti-Ig  and 
maintained in NH4C1 throughout the completion of the experi- 
ment. The concentrations of NH4C1 used are suf~cient  to block 
antigen presentation (35). B cells were treated with 10 #g/ml cy- 
cloheximide for 3 h before the addition of 3H-pc-anti-Ig and main- 
tained in cycloheximide thereafter. B cells were treated with 100 #M 
anisomycin for 1 h before addition of 3H-pc-anti-Ig and maintained 
in anisomycin  thereafter. To determine the degree of protein syn- 
thesis  inhibition by cycloheximide and anisomycin,  B cells (107) 
were treated as described above followed by a 4-h incubation with 
44/zCi  of 3SS-methionine in  the presence of cycloheximide or 
anisomycin.  The cells were washed with complete media until the 
washes  no longer contained detectable 3sS as measured by liquid 
scintillation  counting.  Treatment  reduced 35S incorporation by 
>90%. 
Measurement of  APC Function.  Either B cells or cells of the CH27 
B  cell  lymphoma line (5  x  104) as APC  (36)  and  TPC9.1 hy- 
bridoma  cells  (5  x  10 4)  (37)  were cocultured overnight  with 
graded doses of antigen. Culture supernatants were removed and 
tested for their IL-2 content by the ability to maintain the growth 
of the ID2-dependent T cell line, CTLL (38). CTLL growth was 
measured  by  the  conversion  of 3-(4,5-dimethyl  thiazol-2yl)-2, 
5-diphenyl tetrazolium bromide (MTT) to a blue formazen product 
having an absorbance at 570 nm (39) or by the incorporation of 
[3H]thymidine  (38). To follow the processing of Pc-anti-Ig, B cells 
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of 0.2/~M, at 4~  washed, and assayed  for the ability to activate 
TPc9.1 cells to Ib2 secretion. [L-2 was measured by the ability of 
culture supernatants to maintain the growth of CTLL cells assayed 
by the incorporation  of [3H]thymidine. 
Results 
Characterization of Radiolabeled Cytochrome c-Antibody Con- 
jugates.  Pc was reductively methylated at lysine residues using 
3H-sodium cyanoborohydride (3H-Pc).  Pc, a 104-amino acid 
protein, contains 18 lysine residues (Fig.  1) spaced relatively 
evenly across the length of the polypeptide chain (40). Thus, 
after methylation to introduce 3H,  most  peptide fragments 
of Pc resulting from processing will be radiolabded and there- 
fore can be detected. Significantly, the major antigenic deter- 
minant  of Pc recognized by  T  cells  and  monitored  here 
(minimally residues 95-104) contains two lysine residues, en- 
suring its detection. Micro-sequencing of a 23-residue COOH- 
terminal peptide fragment generated by CNBr cleavage of 
3H-cytochrome c confirms that all lysine residues in this pep- 
tide are tritiated (data not shown). 
The antigenicity of methylated Pc was compared with un- 
modified Pc. It was predicted that methylation of Pc would 
have little effect on the protein's antigenicity as the charge 
on the lysine residues would not be effected nor would the 
modification significantly increase the size of the residue. In- 
deed, recently published results show that 3H-Drosophih me- 
lanogaster cytochrome c (DMc) and unmodified DMc were 
antigenically comparable with respect to pulsing the B cell 
lymphoma CH27,  thereby indicating that for CH27  cells 
methylation of DMc does not greatly affect its antigenicity 
(20,  27).  Pc  was  modified using  cold  cyanoborohydride, 
chromatographed on an ion exchange resin, resolving three 
populations, designated A, B, and C  (Fig.  2). Similar chro- 
matography of 3H-Pc (Fig. 2) indicates that each population 
contains Pc modified on an average at six lysine residues, and 
thus  the  populations  likely  represent  3H-Pc  modified  at 
different subsets of lysine residues. Methylated and unmodified 
Pc were tested for the ability to be processed and presented 
by B cells to a Pc-specific I-E~-restricted T  cell hybrid, TPc 
9.1 (35).  The methylated pools of Pc were nearly equivalent 
to unmodified Pc in their ability to be processed and presented 
to T cells (Fig. 2). Thus, methylated Pc is processed to a rele- 
vant antigenic peptide fragment and associated with I-E  k in 
B cells. 
To study the processing of antigen internalized after binding 
to the surface Ig, 3H-Pc was covalently coupled to affinity- 
purified rabbit  antibodies  specific for mouse F(ab')2  of Ig 
1  GDVEKGKKIFVQKCSQCHTVEKGGKHKTG  PN LHG 
34  LFGRKTGQAEGFSYTDANKNKGITWGEDTLMEYL 
69  ENPKKYI  PGTKM[  FAG IKKKAERADLIAYL  ATAK 
Figure t.  The amino acid sequence of Pc using standard one-htter amino 
acid abbreviations. The 18 lysine residues have been highlighted and are 
the sites of tritiation. The minimal antigen peptide, Pc 95-104,  is underlined. 
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Figure 2.  Antigenicity  of methylated  Pc. (~p) Pc was reductively  meth- 
ylated using 3H-sodium cyanoborohydride  as described  in the Materials 
and Methods, and the resulting reaction  mixture was fractionated  by ion 
exchange chromatography.  Three pools were formed  from the fractions 
and designated  A, B, and C containing  Pc modified  at 6.9, 5.6, and 5.8, 
lysines respectively.  The unfractionated  mixture  contained  Pc modified  at 
5.8 lysines  on average. (Bottom)  Pc was reductively  methylated  using cold 
sodium cyanoborohydride  and chromatographed  on an ion exchange  resin 
as above. Pools A, B, and C were buffer changed into PBS and graded 
doses of each pool were  compared  with respect to unmodified  Pc for their 
ability to stimulate TPCg.1 cells to secrete  IL-2. 
(3H-Pc-anti-Ig).  Ig-mediated internalization of antigen was 
considered desirable both because it likely represents the major 
route of antigen entry into B cells under physiological condi- 
tions and because it would allow concentration of antigen 
into the processing pathway facilitating its detection. Indeed, 
earlier studies showed that coupling Pc to Ig-specific anti- 
bodies greatly increases the efficiency with which the antigen 
is processed (28), allowing formation of maximal numbers 
of processed antigen-MHC class II complexes using ,'o0.1% 
the concentration required for Pc alone. 3H-Pc-anti-Ig binds 
to B cells at 4~  in a concentration-dependent fashion and 
can be competed by unmodified Ig-specific antibodies, indi- 
cating specific binding to surface Ig (Fig. 3). To compare the 
incorporation of Pc and Pc-anti-Ig during processing, B cells 
were incubated for 6 h  at 37~  with 3H-Pc-anti-Ig or 3H- 
Pc, washed, and cell-associated radioactivity was measured 
(Fig. 3). Radioactivity is detectable in B cells incubated with 
as little as 0.005  #M 3H-Pc-anti-Ig, whereas >500-fold as 
much 3H-Pc is required to reach the same level of incorpo- 
ration. The ability to measure radioactivity associated with 
B cells incubated with as little as 0.005/zM  3H-Pc-anti-Ig 
indicates the technical feasibility of monitoring 3H-Pc-anti- 
Ig as it is processed by the B cell, which would not be pos- 
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incubated with graded concentrations of either 3H-Pc (squares) or 3H-Pc- 
anti-Ig (circles) for 6 h.  The cells were pelleted, washed twice in FCS, 
resuspended in DME, and cell associated  radioactivity was measut~l. (Inset) 
B cells (5  x  107) were incubated with sH-Pc-anti-Ig (0.08 #M) and graded 
doses of unlabeled rabbit anti-mouse F(ab')2  for 1 h on ice. The cells were 
washed twice with FCS, and the amount of cell-associated radioactivity 
was measured. 
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Figure  4.  Time dependence of antigen  internalization  and degradation. 
(~p) B cells were assayed for the internalization and degradation of 3H- 
Pc-anti-Ig as detailed in Materials and Methods.  Briefly, B cells (1.2  x 
10  s) were incubated with 0.2/~M 3H-Pc-anti-Ig in 25% normal rabbit 
serum in complete  medium for  1 h  on ice, washed  twice with FCS, 
resuspended in 6 ml of complete media, and aliquoted and incubated for 
the times indicated. The radioactivity in the released, cell surface, and in- 
ternal fractions was measured. Shown are the cpm in each fraction versus 
time at 37~  (Bottom)  Each fraction was brought to 10% TCA and in- 
cubated on ice for 90 min. The precipitate was pelleted by centrifugation 
at 16,000 g for 45 rain. An aliquot of the TCA-soluble supematant was 
removed and counted by liquid scintillation. The data are expressed as the 
total cpm contained in each fraction versus the time at 37~ 
30 and 60 min, and the amount increases  with continued 
incubation at 37~  A small but detectable amount of radio- 
activity appears on the cell surface by 60 min. This amount 
remains  on  the  surface for  1-2  h  and  gradually declines 
returning to background levels by 8 h.  As will be shown 
below, a portion of the cell surface-associated radiolabeled 
antigen is bound to the I-E  k molecules. There is no detect- 
able TCA-soluble material inside the cell at any time, indi- 
cating that there is not a significant intracellular pool of free 
antigenic peptides. 
The released, surface, and internal fractions were analyzed 
by molecular sieve chromatography to gain additional infor- 
mation concerning the size of the processed antigen (Fig. 5). 
The time course of the appearance of degraded antigen is 
similar to that obtained monitoring TCA-soluble material. 
The first degradation products are detected in the released 
fraction and on the cell surface 30-60 min after warming to 
37~  while no free peptides are detected at any time in the 
internal fraction. The bulk of the first processed peptides de- 
tected both in the supernatant and on the cell surface are small 
(<25 residues). It is striking that no intermediate degrada- 
tion products between the whole conjugate or Pc and small 
peptides are detectable at any time, suggesting that processing 
sible relying on fluid phase uptake of the antigen. Further- 
more, the amount of Pc-anti-Ig bound to B cells after incu- 
bation at 4~  with the conjugate at 0.2/~M Pc, a concentration 
used in all subsequent experiments, is suftident for presenta- 
tion to T  cells.  Indeed, B cells incubated at 4~  with the 
Pc-anti-Ig conjugate and washed are able to stimulate TPc9.1 
cells  to IL-2 secretion (data not shown). 
Bindin~ Internalization, and Degradation of [3H]Pc-Anti-Ig by 
B Cells.  To further characterize the processing of 3H-Pc- 
anti-Ig, B cells were incubated with 3H-Pc-anti-Ig (0.2/xM) 
on ice for 1 h, washed, resuspended in complete media, and 
incubated at 37~  for varying lengths of time. Radioactivity 
was measured in three fractions: in the culture supernatant 
(released); associated at the cell surface, defined as that which 
is removed from cells by acid treatment (surface); and intra- 
cellular, defined as that which is not removed from cells by 
acid treatment (internal) (Fig. 4). At the initiation of the ex- 
periment, we calculate that ~6  x  103 3H-Pc-anti-Ig con- 
jugates are bound to each cell B lymphocyte considering a 
specific activity of the conjugate of 5  x  1016 cpm/mol 3H- 
Pc. Upon warming, the majority of the 3H-Pc-anti-Ig is in- 
ternalized within 15-30 min. With continued incubation at 
37~  a small portion of 3H-Pc-anti-Ig reappears on the sur- 
face, which may be recycled antigen bound to surface Ig. Over 
time at 37~  the amount of cell surface and internal antigen 
gradually decreases while the amount in the supernatant in- 
creases. 
To determine at what point the 3H-pc-anti-Ig is processed 
to peptide fragments, the released,  surface, and internal frac- 
tions were each precipitated with TCA (Fig. 4). The radio- 
activity in solution, representing small peptides, was mea- 
sured. Peptides are first detected in the released fraction between 




Void  Pc81 -  104 
l 
4  ￿9  -  -  ￿9  t  i  ! 
￿9  Surface 
0  min. 
3 
￿9  Released 
2  ~  ￿9  Internal 
￿9 .R_  _  .........  - ........... 
0  ....  !  ,  III  .  .  .  ;  -  !  :  .  :  ,  =  . 




0  ....  I  ,  .  .  .  .I  ,  .  .  .  .  ~1  . 
60  rain. 
3 
2 
:  .  .  ,.~.~.-...  ,.  ,  ."~..,  .,:  . 




0  I  ,  "  ""  "  iii1_ 
0  50  1 O0  150 
Fraction  Number 
Figure 5.  Molecular sieve  chromatography of processed antigen. B cells 
(1.2  x  10  s) were incubated with aH-Pc-anti-Ig for I h at 4~  washed, 
aliquoted, and incubated at 37~  for the times indicated, as described in 
Fig. 4. The released, cell surface, and internal fractions were colleeted and 
then chromatographed  on a  Sephadex G-50sf column (1  x  33  cm) 
equilibrated in 7% formic acid. The eluate was collected in 200-/zl frac- 
tions and counted by liquid scintillation. 
occurs in a highly degradative compartment where proteol- 
ysis goes to completion unless peptides are protected in some 
fashion. 
To relate the observed patterns of  internalization and degra- 
dation (Fig. 4) to antigen presentation,  we determined the 
effects  of documented inhibitors of APC function in this assay. 
In three separate experiments we evaluated the effects of re- 
duced temperature,  NH~, and cycloheximide on the inter- 
nalization and degradation  of 3H-Pc anti-Ig.  Reduced tem- 
perature (4~  blocks both the internalization of the antigen 
by B cells and degradation of antigen bound to B cell surface 
Ig (Fig. 6), consistent with its effect on the ability of APC 
to stimulate T cells at reduced temperature.  Treatment of B 
cells with the lysosomotropic  agent NH4C1 for 1 h before 
incubation with 3H-Pc-anti-Ig completely blocks the degra- 
dation of the antigen,  as shown by the complete absence of 
any TCA-soluble material in the released, cell surface, and 
internal fractions at any time (Fig. 6). NH4CI has little effect 
on the binding and internalization  of the conjugate,  how- 
ever, there is a marked decrease in the amount of antigen 
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Figure 6.  The effect of inhibitors on antigen internalization  and degra- 
dation. Shown is a composite of the results of three separate experiments 
for which untreated cell controls were carried out for each. (~p) The in- 
ternalization and degradation assay  was carried out on B cells as described 
in Fig. 4 except the cells were maintained at 4~  for the times indicated. 
In control experiments where cells were warmed to 37~  after 3H-Pc- 
anti-Ig binding  at 4~  internalization and degradation patterns were similar 
to those shown in Fig. 4. (M/rid/e)  B cells  were incubated  in complete medium 
alone or complete medium containing 10 mM NH4CI at 37~  for 1 h 
before and during the assay for antigen internalization and degradation 
as in Fig. 4. Shown are results for NH4-treated cells. Control, untreated 
cells initially bound 4.5  x  104 cpm 3H-Pc anti-Ig, and the internaliza- 
tion and degradation pattern were similar to those shown in Fig. 4. (Bottom) 
B cells were incubated in complete medium alone or complete medium 
containing 10/~g/ml cycloheximide at 37~  for 3 h before and during 
the assay for antigen internalization  and degradation as in Fig. 4. Shown 
are results for cycloheximide-treated cells. Control untreated cells initially 
bound 1.5  x  104 cpm 3H-Pc anti-Ig and internalization and degradation 
patterns  appeared similar to those shown in Fig. 4. 
in the released fraction and consequently a large portion of 
the antigen remains cell associated (Fig. 6). The inability of 
NH4Cl-treated  B cells to degrade the internalized  antigen 
may block the release of the antigen, therefore resulting in 
its accumulation in the cell. The effect of NH4C1 on antigen 
degradation in this assay is consistent with its documented 
ability to block APC function in T cell activation.  Cyclo- 
heximide treatment has little effect on the binding, internali- 
zation,  or degradation  of antigen resulting in TCA-soluble 
material in the surface and released fractions (Fig. 6). Thus, 
cycloheximide's  ability to block APC function in B cells must 
be due to a requirement for new protein synthesis in antigen 
presentation  not measured in this assay. 
430  Assembly of Processed Antigen-I-E  k Complexes in B Cells Figure 7.  The kinetics of the as- 
sembly of processed antigen-MHC 
class II complexes in B cells. B cells 
(6  x  10  s) were incubated in com- 
plete media with 3H-Pc-anti-Ig for 
1 h on ice, washed thoroughly, and 
resuspended in complete media at 
107 cells/ml. Aliquots of cells (10  s) 
were maintained at 37~  for the in- 
dicated times, pelleted, and frozen. 
Pellets were thawed, solubilized,  and 
immunoprecipitated  with  either 
I-E  k- or B220-specific mAbs as de- 
scribed in Materials and Methods. 
The radioactivity in the precipitates 
is given with time at 37~  Each 
data point represents between 2 and 
10 immunoprecipitations  carried out 
in independent  experiments. (Inset) 
B cells were surface  iodinated as de- 
scribed in Materials and Methods. 
The cells were resuspended in com- 
plete  media  at  107  cells/ml,  and 
1-ml  aliquots  were  incubated  at 
37~  for varying lengths of time. 
The cells were pelleted and immu- 
noprecipitated  with  I-E~-specific 
mAbs as described. Precipitates were analyzed by SDS-PAGE on a 10.5% polyacrylamide gel and shown is the autoradiograph  of samples after 0, 2, 
4, 6,  and 8 h of incubation at 37~  Surface iodination results in the labeling of only the 3  chain of I-E  k as previously shown which migrates at 
35 kD (20). 
The Assembly of  Processed  Antigen-MHC Class  II Complexes 
in B Cells.  To directly measure the binding of processed an- 
tigen  to  the  I-E  k molecules,  the  kinetic  experiments  de- 
scribed above were repeated and at the end of each time point 
the I-E  k molecules were immunoafEnity purified and the as- 
sociated  radioactivity was  measured.  As  discussed  above, 
previous studies showed that functional processed antigen- 
I-E  k complexes are stable to affinity purification, that the as- 
sociation of processed antigen with I-E  k in B cells is highly 
specific, and that ,~800-1,000 of the I-E  k molecules in each 
cell contained processed antigen (20, 27).  Radiolabeled an- 
tigen is first immunoprecipitated with I-E  k "~1 h  after in- 
ternalization of 3H-Pc-anti-Ig (Fig.  7).  The amount of ra- 
dioactivity precipitated is maximal at 2 h and remains at that 
level for the next 2 h.  This time course is consistent with 
our previously published time course of the acquisition of 
the ability of B cells to process antigen so  as to  stimulate 
specific T cells (41). The radioactivity precipitated with I-E  k 
at 2 h represented '~2% of the 3H-Pc anti-Ig initially bound 
to the cell surface.  From previous studies (20) in which the 
number of processed antigen-I-E  k complex was measured by 
direct biochemical methods, we estimate that this represents 
,o800-1,000  complexes in the immunoprecipitate. The as- 
sociation of antigen with I-E  k is specific as radioactivity is 
not immunoprecipitated with proteins other than MHC class 
II.  Indeed, no radioactivity is associated with B220 mole- 
cules (Fig.  7) under conditions where equivalent quantities 
of I-E  k and B220  are immunoprecipitated as  measured by 
3SS-methionine-labeled  protein analyzed by SDS-PAGE (data 
not shown). The association of processed antigen with I-E  k 
is unlikely to be the result of released peptides binding to 
surface I-E  k because processed antigen-I-E  k complexes begin 
to disappear after 4 h (Fig. 7), while the amount of  processed 
antigen in the supernatant continues to increase up to 8 h 
(Fig.  4). 
To assess the requirement for acidic vesicle function for the 
formation of processed antigen-MHC class II complexes, B 
cells were pretreated at 37~  with NH4CI for 1 h before in- 
cubation with 3H-Pc-anti-Ig for 1 h at 4~  The cells were 
then washed, and incubated at 37~  for 2 h in the continued 
presence of NH4C1 to allow time for maximal processed an- 
tigen-MHC dass II complex formation. The I-E  k and B220 
molecules were immunoprecipitated from cell lysates. Treat- 
ment with NH4C1 completely blocks processed antigen-I-E  k 
complex formation (Fig.  8),  consistent with  the effect of 
NH4CI on presentation of antigen as measured by the ability 
of B cells to activate T cells (35).  Indeed, as shown (Fig. 6), 
3H-Pc-anti-Ig is internalized but  not  degraded in  NH4C1- 
treated B cells indicating that antigen-MHC class II com- 
plexes cannot form unless the internalized antigen is degraded. 
To assess the requirement for new protein synthesis on the 
assembly of processed antigen-MHC class II complexes, B 
cells  were incubated with either cycloheximide for 3  h  or 
anisomycin for 1 h before incubation with 3H-Pc-anti-Ig  for 
1 h  at 4~  The ceils were washed and incubated at 37~ 
for 2 h  in the continued presence of the inhibitors.  In the 
presence of cycloheximide or anisomycin, B cells  assemble 
"~75 % of the complexes assembled in untreated B cells (Fig. 
8).  Thus,  new protein synthesis for 4 h  preceding antigen 
internalization is not required for assembly of the processed 
antigen-I-E  ~ complexes.  Since newly synthesized I-E  k is not 
required for peptide association,  the processed antigen-MHC 
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class II complexes may either be derived from a long-lived 
intracellular pool of I-E  k or from a population  of I-E  k recy- 
cling from the B cell surface. 
The Disassembly or Degradation of Processed Antigen-I-E  k 
Complexes  in  B  Cells.  Processed antigen-I-E  k complexes 
gradually decrease with time 4 h after formation, such that 
by 6-8 h no peptide-MHC class II complexes are detected 
(Fig. 7). This time course is consistent with our previously 
published time course of the loss of the ability of B cells to 
activate specific  T cells once antigen has been processed (41). 
There is considerable variability in the amount of processed 
antigen-I-E  k complexes detected after 4 h of incubation at 
37~  This appears to represent variation between B cell prepa- 
rations in each of five independent experiments. Freshly iso- 
lated spleen B cell preparations in two experiments showed 
no loss of processed antigen-I-E  k complexes at 4 h (1,192 +_ 
236 cpm), while in three experiments B cells showed significant 
loss of complex (490  _+  128 cpm). 
The Peptide-I-E  k complexes disappear from B cells within 
6-8 h,  even though there is no detectable decrease in the 
amount of I-E  k on the cell surface over the 8-h period (Fig. 
7). B cell surface proteins were labeled with 145I using lac- 
toperoxidase, incubated for varying lengths of time at 37~ 
and the I-E  k molecules immunoprecipitated. The cell surface 
I-E  k shows no decrease over 8 h, indicating that the loss of 
the processed  antigen-MHC class II complexes  does not reflect 
the turnover rate of the bulk of the I-E  k. 
The disassembly or degradation of the processed antigen- 
MHC class II complexes requires acidic vesicle function (Fig. 
9).  B cells were incubated  at 4~  with 3H-Pc-antigen-Ig, 
washed, warmed to 37~  and incubated  for 2 h to allow 
maximal complex  formation. At the end of 2 h,  NH4C1 
(final concentration, 10 mM) was added to cultures, and the 
cells were incubated for additional periods of time. At the 
end of each period,  I-E  k was immunoprecipitated from ly- 
sates. In the presence of NH4CI the complexes are stable and 
can be purified 8 h later at a time when no complexes can 




Figure 8.  The effects of inhibitors of antigen processing 
on the assembly of processed antigen-MHC class II com- 
plexes. B cells (10  s) were preincubated with the indicated 
inhibitors as described in Materials and Methods, then in- 
cubated with 3H-Pc-anti-Ig in the continued presence of 
the inhibitor at 4~  for 1 h. The cells were washed and 
resuspended at 107 cells/ml in complete media containing 
the inhibitor and incubated  at 37~  for 2 h.  The cells 
were pelleted and subjected to immunoprecipitation,  as 
in Fig.  6.  Shown is the cpm immunoprecipitated  with 
I-E  k.  In each case, insignificant  cpm were immunopre- 
cipitated using the the B220-specific antibody  (90  _+  27 
cpm). 
sembly and/or degradation of complexes requires functional 
acidic vesicles and does not correlate with the turnover time 
of the bulk of the I-E  k. 
Discussion 
Considerable progress has been made in understanding the 
discrete intracellular steps in the synthesis and assembly of 
the MHC class II molecules and in the binding of synthetic 
Peptides to purified MHC class II in vitro. However, the mo- 
lecular mechanisms by which antigen is degraded and pep- 
tide fragments associated with the MHC class II inside cells 
remain, for the most part, uncharacterized. Here we describe 
biochemical assays  for the binding, internalization, and degra- 
dation of radiolabeled antigen initially bound to surface Ig 
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Figure  9.  The loss of processed antigen-I-E  k complexes requires acidic 
vesicle function. B cells were incubated  with 3H-Pc-anti-Ig and treated 
as in Fig. 7. After a 2-h incubation  at 37~  NH4CI (10 mM) was added 
to cells and incubated at 37~  continued  for varying lengths of time. I-E  k 
was immunoprecipitated  as in Fig.  7. 
432  Assembly of Processed Antigen-I-E  k Complexes  in B Cells class II complexes. The results of the studies presented here 
using these assays afford a number of insights into the mech- 
anisms of antigen processing. 
The assembly of processed antigen-MHC class II com- 
plexes is relatively rapid in that complexes are measurable by 
2 h. Our earlier studies showed that splenic B cells require 
4-6 h to process antigen so as to activate specific  T cells (41). 
However, it was not known if the time requirement was for 
the formation of the complexes themselves or the transport 
and/or accumulation of processed antigen-MHC class II com- 
plexes on the B cell surface. Here we show that antigen bound 
to surface Ig is internalized within minutes, and degradation 
products detected ,,ol h later, at the same time processed an- 
tigen-I-E  u complexes are first detected and ~2-4 h before 
T  cells are activated. Thus, there is a short lag period be- 
tween the time the first complexes are formed and the time 
T cells are activated. At present the rate-limiting steps in ei- 
ther the formation of processed antigen-MHC class II com- 
plexes or the display on the cell surface of such complexes 
are not known. Published  studies show that the c~ and fl 
chains of MHC class II and Ii chains are rapidly assembled 
and transported through the Golgi compartment and then 
reside for at least 1-2 h in a post-Golgi compartment, before 
cell surface expression of the ce and fl chains (4, 6). During 
this time the oe and fl chains dissociate from the Ii chain and 
the MHC class II molecules take on a final native form, pre- 
sumably with processed antigen bound. The process of Ii 
chain dissociation and final assembly of o~ and fl chains with 
processed antigen may account for the observed time require- 
ment for formation of complexes. The time that elapses be- 
fore the B cells are able to activate  T cells  may represent the time 
necessary to acquire  a threshold number of processed an- 
tigen-MHC class II complexes on the B cell surface. The 
time requirement may also reflect the accumulation of other 
accessory molecules on the B cell surface that facilitate inter- 
action with T cells. The recruitment of additional accessory 
molecules may be triggered by the binding of the antigen- 
antibody conjugate to the B cell surface Ig. 
The rate of intracellular  assembly of peptide-I-E k com- 
plexes reported here is far more rapid than the rate of  binding 
of peptide to MHC class II measured in vitro, which shows 
a  tl/2 of binding of 8 h  (22). Several explanations  may be 
offered to account for the observed differences that take into 
account the conformation of  MHC class II molecules required 
for peptide binding and the microenvironment within the 
APC in which binding occurs. Jensen (25) and Wettstein et 
al. (26) have shown enhanced binding of peptide to MHC 
class II at reduced pH in vitro, presumably mimicking the 
environment within the acidic compartments of the APC. 
Although the effect of pH on the MHC class II molecules 
is not known, these findings suggest that conformation and/or 
chemical properties of the MHC class II are not identical at 
all pHs and are more favorable for peptide binding at reduced 
pH.  In this regard, we have recently observed that MHC 
class II bound to newly processed antigen can be distinguished 
from the bulk of MHC dass II in B cells by migration on 
SDS-PAGE (20). Indeed, the two forms of I-E  k observed in 
our studies are reminiscent of the compact and floppy forms 
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ofdass II described by Dornmair et al. (42). Although there 
are several explanations for such a change in the migration 
pattern, it is interesting to speculate that the class II may 
have two conformations: one that accommodates peptide and 
one that does not. Another possible explanation of the differ- 
ences in results of peptide-MHC class II binding studies in 
vitro and in the APC may be found in the fact that studies 
in vitro have used model, minimal length synthetic peptides 
that may not represent the optimal length of peptides for 
binding to MHC class II in the cell. Preliminary amino acid 
sequence analysis indicates that the predominant processed 
cytochrome c peptide bound to I-E  k is considerably longer 
than the minimal length peptide (20). It is possible that the 
length of the peptide and thus its chemical composition affects 
binding to class II.  Last, with regard to processed antigen 
binding to MHC,  there may be accessory proteins  within 
the APC that facilitate binding, such as the recently charac- 
terized peptide binding protein, PBP72/74 (43, 44), which 
has been colocalized to the endosomal  compartments into 
which  antigen bound  to  surface Ig  is  transported  (45). 
PBP72/74 is a new member of the heat shock protein family 
(44). Members of this family share a common function of 
binding to newly synthesized, unfolded or degraded proteins 
and facilitating their refolding or transport in the cell (46). 
We have speculated that PBP72/74 may be involved in the 
transport of processed antigen to the MHC class II and/or 
in the assembly of the processed antigen with the MHC class 
II (47). Clearly, more information is needed concerning  both 
the conformational flexibility of the MHC class II and the 
microenvironment in which processed antigen is bound to 
MHC class II before the reasons for the observed differences 
in peptide binding in vitro and in the APC are understood. 
The results presented here show that once formed, the pep- 
tide-MHC class II complexes are only transiently expressed 
by B cells and that the disappearance of the processed an- 
tigen-I-E  k complexes requires  acidic vesicle function.  An 
acidic vesicle  environment may be required either for the degra- 
dation or for the disassembly of the complexes. However, 
loss of complexes from B cells are more rapid than the mea- 
sured rate of turnover of the bulk I-E  k. In fact, there was no 
measurable degradation of surface I-E  k over the time the pro- 
cessed antigen-MHC class II complexes disappear. If the pro- 
cessed  antigen-MHC complexes  are being degraded, the degra- 
dation mechanism must be selective,  discriminating new pro- 
cessed antigen-MHC class II complexes from the bulk of the 
MHC class II. In this regard, as discussed above, we recently 
showed that the MHC class II purified from cells that have 
processed antigen and that are bound to processed antigen 
can be distinguished  from the bulk of MHC class II mole- 
cules by their migration in SDS-PAGE (20). It is possible 
that such newly processed antigen-MHC class II complexes 
can be discriminated from the majority of MHC class II in 
B cells and be selectively targeted for degradation.  Alterna- 
tively, the disappearance of processed antigen-MHC class II 
vesicles may represent the dissociation of the processed an- 
tigen from MHC class II in acidic vesicles. Although not 
all investigators have observed MHC class II cycling from 
the cell surface (4, 48), when reported, the cycling rates for MHC class II are fast, with ~20% recycling every 30 min 
(15, 16). Processed antigen-MHC class II complexes may be 
taken into acidic compartments in which the release of the 
bound processed antigen is facilitated. It remains to be deter- 
mined whether the acidic vesicles in which processed antigen 
binds to MHC class II molecules and in which disassembly 
or degradation occurs are one and the same. 
As commented on above, an issue that has not been com- 
pletely resolved is  whether the MHC  class  II  that  binds 
processed antigen is from a newly synthesized pool that has 
not reached the cell surface,  from a surface recycling pool, 
or from both. Experiments that show that inhibitors of pro- 
tein synthesis block the ability of APC, when provided with 
native antigen, to stimulate T cells have been interpreted to 
indicate that newly synthesized MHC class II is required for 
presentation (12, 13). However, as is shown here, hours after 
new protein synthesis is blocked, peptide-MHC class II com- 
plexes are still assembled. This suggests that the requirement 
for new protein synthesis is for the presentation of these com- 
plexes to T  cells. The MHC class II that binds peptide in 
the presence of protein synthesis inhibitors may be from a 
long-lived intracellular pool of MHC class II delayed in its 
transport to the cell surface (4, 6) or from recycling MHC 
class II molecules (15,  16). 
Another observation to note is that the antigen internal- 
ized by B cells is degraded immediately to small peptides with 
no larger intermediates detected at any time. This suggests 
that the compartment in which proteolysis occurs is highly 
degradative and that degradation of the antigen would go 
to completion if peptides were not protected in some way. 
If MHC class II is indeed present in this compartment, it 
could serve this function. Recent evidence by Brodsky and 
coworkers (10) indicates that MHC class II, Ii chain, and pro- 
teases colocalize in the same compartment into which an- 
tigen bound to Ig is transported. If this is the compartment 
in which degradation occurs, peptides may bind directly to 
MHC class II.  Alternatively, other APC proteins such as 
PBP72/74,  discussed above (43, 44), might be required to 
scavenge processed antigen in this or from other degradative 
compartments and deliver the peptides to the MHC class II 
for binding.  In support  of this possibility,  PBP72/74  was 
colocalized to  '~35%  of the compartments  described by 
Brodsky and coworkers (45), indicating that PBP72/74 may 
function at this site. 
The kinetics of the assembly and disassembly of processed 
antigen-MHC class II complexes reported here are for normal 
splenic B cells. Whether similar kinetics will be observed for 
other APC or for transformed cell lines remains to be seen. 
An important aspect of the studies described here is that pro- 
cessing is initiated by B cells binding antigen to surface Ig. 
The surface Ig is a well-documented signal transducing receptor 
(49) and binding antigen has been shown to signal for en- 
hanced antigen processing by an as yet undefined mechanism 
(37).  The assembly and disassembly rates of processed an- 
tigen-MHC complexes may be regulated by antigen binding 
to surface Ig, allowing for regulation of the time during which 
T  cells may interact with B cells.  It will be of interest to 
determine if other regulators of B cells, such as interleukins, 
affect assembly and disassembly rates and whether other APC 
have mechanisms to regulate such processes. 
In summary, the ability to directly measure the intracel- 
lular assembly of processed antigen-MHC class II complexes 
provides a link between the studies of the biosynthesis of 
MHC class II and the requirement for T cell activation. The 
results obtained thus far lend important insights into the pro- 
cess, and the assay may help further delineate discrete steps 
in the processing pathway. 
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